2010
DOI: 10.1016/j.nlm.2009.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Interacting noradrenergic and corticosteroid systems shift human brain activation patterns during encoding

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
92
1
1

Year Published

2010
2010
2016
2016

Publication Types

Select...
6
3
1

Relationship

2
8

Authors

Journals

citations
Cited by 122 publications
(104 citation statements)
references
References 75 publications
10
92
1
1
Order By: Relevance
“…However, and most importantly, the present findings indicate that such a glucocorticoid/norepinephrine-induced disruption of mPFC functioning induces not only impairment of working memory but also enhancement of long-term memory consolidation. Findings of a recent functional imaging study in human subjects are consistent with this view and indicate that the combined administration of glucocorticoid and noradrenergic agonists during the encoding of emotionally arousing material induces a strong deactivation of the PFC and that the level of deactivation correlates positively with enhanced performance on a retention test given 1 wk later (41). It should be emphasized, however, that the consequences of glucocorticoid (or norepinephrine) administration and PKA activation on cellular physiology within the mPFC, especially during task performance, are far from clear (42).…”
Section: Discussionsupporting
confidence: 56%
“…However, and most importantly, the present findings indicate that such a glucocorticoid/norepinephrine-induced disruption of mPFC functioning induces not only impairment of working memory but also enhancement of long-term memory consolidation. Findings of a recent functional imaging study in human subjects are consistent with this view and indicate that the combined administration of glucocorticoid and noradrenergic agonists during the encoding of emotionally arousing material induces a strong deactivation of the PFC and that the level of deactivation correlates positively with enhanced performance on a retention test given 1 wk later (41). It should be emphasized, however, that the consequences of glucocorticoid (or norepinephrine) administration and PKA activation on cellular physiology within the mPFC, especially during task performance, are far from clear (42).…”
Section: Discussionsupporting
confidence: 56%
“…Together, the beneficial effects of the fMRI setup on memory performance for all scenes might have masked the more subtle effects of poststimulus arousal. Moreover, when NA levels are elevated in addition to cortisol, there is no additive effect on memory performance (van Stegeren et al, 2010;Kukolja et al, 2011). Contrary to the neutral stimuli in the current study, the memory for emotional stimuli is enhanced in fMRI settings as well.…”
Section: Behavioral Performancecontrasting
confidence: 59%
“…We used a double-blind, placebocontrolled between-subjects design in which participants were randomly assigned to one of four experimental conditions: (1) oral placebo (7 men, 8 women; plac); (2) oral placebo and hydrocortisone (20 mg, Jenapharm) (8 men, 7 women; placϩcort); (3) oral placebo and yohimbine (20 mg, Desma), a blocker of the ␣2 adrenergic receptor that stimulates central noradrenergic activity (9 men, 9 women; placϩyoh); (4) oral hydrocortisone and yohimbine (10 men, 9 women; Cortϩyoh). Drug doses were chosen in accordance with earlier studies (Buchanan and Lovallo, 2001;van Stegeren et al, 2010).…”
Section: Methodsmentioning
confidence: 99%